Online Education Is Fastest Growing Segment Fueling The Growth Of EPA And DHA Market
EPA And DHA Market |
Market Overview:
EPA and DHA are two key omega-3 fatty acids that have anti-inflammatory and cardiovascular health benefits. They are used in food fortification and dietary supplements to fulfill the need for omega 3-6 fatty acid balance in regular diets.
Market key trends:
The rising awareness about the health benefits of EPA and DHA among the population is a major factor responsible for the growth of the EPA and DHA market. Omega-3 fatty acids have been found to reduce cardiovascular disease risk when consumed in addition to a healthy diet. Research suggests that consumption of EPA and DHA may help lower blood pressure and reduce the production of compounds in the body that can cause inflammation. This consumer awareness is boosting the demand for EPA and DHA products in supplements, infant formula, and food fortification applications.
Segment Analysis
The global EPA and DHA market is segmented into application and form. Based on application, the market is segmented into dietary supplements, functional foods & beverages, pharmaceuticals, infant formula, and animal feed & pet food. The dietary supplements segment dominated the market in 2022 and is expected to continue its dominance over the forecast period due to rising health-consciousness among consumers and increasing usage of omega-3 supplements for several health conditions.
The EPA and DHA Market Share is estimated to be valued at US$ 1853.38 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights
Key Takeaways
The global EPA and DHA market is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasinghealth consciousness among consumers and rising awareness regarding the health benefits of consuming EPA and DHA.
Regional analysis
North America dominated the global EPA and DHA market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to strong demand for functional foods and dietary supplements containing EPA and DHA, increasing consumer awareness regarding the health benefits of omega-3 fatty acids, and rising focus of key players on business expansion in the region. The Asia Pacific market is expected to witness the fastest growth over the forecast period due to growing health consciousness, rising disposable income, and increasing consumption of nutritional supplements in countries like China and India.
Key players
Key players operating in the EPA and DHA market are Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris. Koninklijke DSM NV is one of the leading players focusing on expanding its global footprint and reinforcing its supply chain to strengthen its position in the market.
Comments
Post a Comment